JP2025072466A5 - - Google Patents
Info
- Publication number
- JP2025072466A5 JP2025072466A5 JP2025015899A JP2025015899A JP2025072466A5 JP 2025072466 A5 JP2025072466 A5 JP 2025072466A5 JP 2025015899 A JP2025015899 A JP 2025015899A JP 2025015899 A JP2025015899 A JP 2025015899A JP 2025072466 A5 JP2025072466 A5 JP 2025072466A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- administration
- subject
- administered
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752832P | 2018-10-30 | 2018-10-30 | |
| US62/752,832 | 2018-10-30 | ||
| US201962860565P | 2019-06-12 | 2019-06-12 | |
| US62/860,565 | 2019-06-12 | ||
| US201962881137P | 2019-07-31 | 2019-07-31 | |
| US62/881,137 | 2019-07-31 | ||
| PCT/US2019/058824 WO2020092533A2 (en) | 2018-10-30 | 2019-10-30 | Methods of treatment using anti-cd123 immunoconjugates |
| JP2021548551A JP7630435B2 (ja) | 2018-10-30 | 2019-10-30 | 抗ｃｄ１２３免疫複合体を用いた治療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548551A Division JP7630435B2 (ja) | 2018-10-30 | 2019-10-30 | 抗ｃｄ１２３免疫複合体を用いた治療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025072466A JP2025072466A (ja) | 2025-05-09 |
| JP2025072466A5 true JP2025072466A5 (https=) | 2026-02-16 |
Family
ID=70464182
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548551A Active JP7630435B2 (ja) | 2018-10-30 | 2019-10-30 | 抗ｃｄ１２３免疫複合体を用いた治療法 |
| JP2025015899A Pending JP2025072466A (ja) | 2018-10-30 | 2025-02-03 | 抗ｃｄ１２３免疫複合体を用いた治療法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548551A Active JP7630435B2 (ja) | 2018-10-30 | 2019-10-30 | 抗ｃｄ１２３免疫複合体を用いた治療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20200157228A1 (https=) |
| EP (1) | EP3873524B8 (https=) |
| JP (2) | JP7630435B2 (https=) |
| KR (1) | KR20210087951A (https=) |
| CN (2) | CN118557748A (https=) |
| AU (1) | AU2019370291B2 (https=) |
| CA (1) | CA3117493A1 (https=) |
| IL (1) | IL282685A (https=) |
| MA (1) | MA54088A (https=) |
| SG (1) | SG11202103999VA (https=) |
| TW (1) | TWI870363B (https=) |
| WO (1) | WO2020092533A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3137454A1 (en) | 2019-04-29 | 2020-11-05 | Immunogen, Inc. | Therapeutic combinations comprising anti-cd123 immunoconjugates |
| US20250345449A1 (en) * | 2024-05-10 | 2025-11-13 | Immunogen, Inc. | Anti-cd123 immunoconjugates for the treatment of blastic plasmacytoid cell neoplasm |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| KR101270829B1 (ko) | 2004-09-23 | 2013-06-07 | 제넨테크, 인크. | 시스테인 유전자조작 항체 및 접합체 |
| WO2008127735A1 (en) * | 2007-04-13 | 2008-10-23 | Stemline Therapeutics, Inc. | Il3ralpha antibody conjugates and uses thereof |
| JP2011509675A (ja) | 2008-01-18 | 2011-03-31 | メディミューン，エルエルシー | 部位特異的コンジュゲーションのためのシステイン操作抗体 |
| AU2010270979B2 (en) | 2009-06-22 | 2015-04-23 | Medimmune, Llc | Engineered Fc regions for site-specific conjugation |
| SI2900277T1 (sl) * | 2012-12-13 | 2022-05-31 | Immunomedics, Inc. | Odmerki imunokonjugatov protiteles in SN-38 za boljšo učinkovitost in zmanjšano toksičnost |
| CA2911499A1 (en) * | 2013-05-14 | 2014-11-20 | Immunogen, Inc. | Anti-folr1 immunoconjugate dosing regimens |
| CN115124573A (zh) * | 2013-09-02 | 2022-09-30 | 杭州多禧生物科技有限公司 | 应用于细胞结合分子-药物共轭体的新型细胞毒性分子 |
| TW201709932A (zh) * | 2015-06-12 | 2017-03-16 | 西雅圖遺傳學公司 | Ｃｄ１２３抗體及其共軛物 |
| ES2887273T3 (es) | 2015-06-29 | 2021-12-22 | Immunogen Inc | Anticuerpos anti-CD123 y conjugados y derivados de los mismos |
| EP3769787A1 (en) | 2015-06-29 | 2021-01-27 | ImmunoGen, Inc. | Conjugates of cysteine engineered antibodies |
| TWI845890B (zh) * | 2016-11-23 | 2024-06-21 | 美商伊繆諾金公司 | 苯二氮平衍生物之選擇性磺化 |
| TW202021618A (zh) * | 2018-08-17 | 2020-06-16 | 美商２３與我有限公司 | 抗ｉｌ１ｒａｐ抗體及其使用方法 |
-
2019
- 2019-10-30 US US16/668,257 patent/US20200157228A1/en not_active Abandoned
- 2019-10-30 CN CN202410406681.5A patent/CN118557748A/zh active Pending
- 2019-10-30 JP JP2021548551A patent/JP7630435B2/ja active Active
- 2019-10-30 CN CN201980073676.4A patent/CN113329768A/zh active Pending
- 2019-10-30 CA CA3117493A patent/CA3117493A1/en active Pending
- 2019-10-30 WO PCT/US2019/058824 patent/WO2020092533A2/en not_active Ceased
- 2019-10-30 AU AU2019370291A patent/AU2019370291B2/en active Active
- 2019-10-30 EP EP19878291.4A patent/EP3873524B8/en active Active
- 2019-10-30 MA MA054088A patent/MA54088A/fr unknown
- 2019-10-30 KR KR1020217014003A patent/KR20210087951A/ko active Pending
- 2019-10-30 TW TW108139297A patent/TWI870363B/zh active
- 2019-10-30 SG SG11202103999VA patent/SG11202103999VA/en unknown
-
2021
- 2021-04-27 IL IL282685A patent/IL282685A/en unknown
-
2022
- 2022-11-09 US US18/054,076 patent/US20230312735A1/en active Pending
-
2025
- 2025-02-03 JP JP2025015899A patent/JP2025072466A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025072466A5 (https=) | ||
| JP2006527193A5 (https=) | ||
| AU2015411525B2 (en) | Combination therapy | |
| JP2021518394A5 (https=) | ||
| CA3008749C (en) | Treatment of ovarian cancer or biliary tract cancer with a combination of gemcitabine-(phenyl-benzoxy-l-alaninyl)]-phosphate and cisplatin | |
| JP2011503075A5 (https=) | ||
| JP2019514974A5 (https=) | ||
| JP2021525735A5 (https=) | ||
| JP2021515017A5 (https=) | ||
| JP2021534165A5 (https=) | ||
| WO2021092134A1 (en) | Dosing regimen for anti-dll3 agents | |
| JP2021523233A5 (https=) | ||
| JP2024069230A5 (https=) | ||
| JPWO2020250915A5 (https=) | ||
| JPWO2022240688A5 (https=) | ||
| JPWO2018213260A5 (https=) | ||
| JPWO2019183253A5 (https=) | ||
| JPWO2019173523A5 (https=) | ||
| IL312514A (en) | Corticosteroid reduction in treatment with anti-cd38 antibodies | |
| US20250019441A1 (en) | Treatment of cancer with anti-ilt2 antibodies | |
| JPWO2019217455A5 (https=) | ||
| IL312515A (en) | Bispecific cd16a binders | |
| JPWO2021016233A5 (https=) | ||
| JPWO2023017252A5 (https=) | ||
| JPWO2023164474A5 (https=) |